新开源：9月19日召开董事会会议

Company Overview - New Source (SZ 300109) announced on September 19 that its 17th meeting of the fifth board of directors was held, discussing the proposal for increasing capital in Huadao (Shanghai) Biomedical Co., Ltd [1] - As of the report, New Source has a market capitalization of 9.4 billion yuan [1] Financial Performance - For the first half of 2025, New Source's revenue composition was as follows: Fine Chemicals accounted for 89.56%, while Medical Services made up 10.44% [1]